Edward Morrow Atkinson III
At a glance: Edward Morrow Atkinson III is Evp, Chief Technical Ops. Off. at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Feb 26, 2026, reported a sale of $325K. On file: 0 purchase lines ($0) and 5 sale lines ($3.6M).
Disclosed holdings: about $9.6M of VRTX stock: 18,432 shares reported on their latest Form 4 (filed Feb 26, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp, Chief Technical Ops. Off. at Vertex Pharmaceuticals Inc / Ma (VRTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Edward Morrow Atkinson III's InsiderPrint
5 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 5 times a year, typically $806K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (5)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Christopher Scott EdmondsPresident · ICE · 100% match
- Ingrid DelaetChief Regulatory Officer · NBIX · 100% match
- Mark E. BunnageEvp, Chief Scientific Officer · VRTX · 100% match
- Shibu NinanChief Accounting Officer · OKTA · 99% match
- Jane PriorChief Marketing Officer · COCO · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 26SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 66818,432 held (−3%) | $486.35 | $325K | +7.2% |
| Feb 19SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2,03121,544 held (−9%) | $489.46 | $994K | +6.5% |
| Feb 19SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 81720,727 held (−4%) | $473.68 | $387K | +10.1% |
| Feb 12SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 1,75122,046 held (−7%) | $460.43 | $806K | +13.2% |
| Nov 19SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2,50016,852 held (−13%) | $434.58 | $1.1M | +20.0% |
- Sell
Evp, Chief Technical Ops. Off. Edward Morrow Atkinson III sold $325K of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Technical Ops. Off. Edward Morrow Atkinson III sold $994K of VRTX at $489.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Technical Ops. Off. Edward Morrow Atkinson III sold $387K of VRTX at $473.68 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Technical Ops. Off. Edward Morrow Atkinson III sold $806K of VRTX at $460.43 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Technical Ops. Off. Edward Morrow Atkinson III sold $1.1M of VRTX at $434.58 — pre-scheduled 10b5-1 plan sale.
Follow Edward Morrow Atkinson III
Get one email when Edward Morrow Atkinson III files a new purchase or sale. Free.
At most one email a day about Edward Morrow Atkinson III, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.